Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAUREEN RAFFERTY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1043314461
CMS profile
364528
Location
CHARLOTTE, NC

General Payments · PY2019–2024

$996.83

  • Reported across 48 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$380.66

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $380.66 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $187.83 9
PY2020 $25.00 2
PY2022 $244.72 13
PY2023 $158.62 7
PY2024 $380.66 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.56 04/30/2024 Food and Beverage Undisputed 01/23/2026 1124810317 CMS
Amgen Inc. $20.73 01/17/2024 Food and Beverage Undisputed 01/23/2026 1117359530 CMS
Amgen Inc. $15.33 03/05/2024 Food and Beverage Undisputed 01/23/2026 1116036845 CMS
Amgen Inc. $20.43 03/11/2024 Food and Beverage Undisputed 01/23/2026 1117359532 CMS
Amgen Inc. $15.24 04/24/2024 Food and Beverage Undisputed 01/23/2026 1117359534 CMS
Amgen Inc. $22.92 06/12/2024 Food and Beverage Undisputed 01/23/2026 1117359536 CMS
Amgen Inc. $17.01 06/25/2024 Food and Beverage Undisputed 01/23/2026 1116036851 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.38 04/01/2024 Food and Beverage Undisputed 01/23/2026 1117849071 CMS
E.R. Squibb & Sons, L.L.C. $19.07 06/05/2024 Food and Beverage Undisputed 01/23/2026 1101369086 CMS
GENZYME CORPORATION $15.70 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139664414 CMS
Janssen Pharmaceuticals, Inc $20.25 01/08/2024 Food and Beverage Undisputed 01/23/2026 1078071674 CMS
Janssen Pharmaceuticals, Inc $22.90 04/15/2024 Food and Beverage Undisputed 01/23/2026 1078071956 CMS
Lilly USA, LLC $23.78 04/10/2024 Food and Beverage Undisputed 01/23/2026 1135186251 CMS
Nevro Corp. $31.22 05/10/2024 Food and Beverage Undisputed 01/23/2026 1130773807 CMS
Novartis Pharmaceuticals Corporation $23.60 02/23/2024 Food and Beverage Undisputed 01/23/2026 1087327921 CMS
Otsuka America Pharmaceutical, Inc. $28.81 06/06/2024 Food and Beverage Undisputed 01/23/2026 1118965613 CMS
UCB, Inc. $40.73 02/26/2024 Food and Beverage Undisputed 01/23/2026 1143436797 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.